Meeting
2019 ASCO Quality Care Symposium
An NLP tool to identify molecular diagnostic testing in veterans with stage IV NSCLC.
Authors
Julie Ann Lynch
VA Health Care System, Salt Lake City, UT
Julie Ann Lynch, Michael J. Kelley, Kyung Min Lee, Anna Hung, Yanhong Li, Bradley J Hintze, Trudy Pendergraft, Melissa Pavilack, Olga Efimova, Scott L DuVall, Shelby D. Reed
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Patient Experience; Safety; Technology and Innovation in Quality of Care
Track
Patient Experience,Technology and Innovation in Quality of Care,Safety
Sub Track
Use of IT/Analytics to Improve Quality
Citation
J Clin Oncol 37, 2019 (suppl 27; abstr 318)
DOI
10.1200/JCO.2019.37.27_suppl.318
Abstract #
318
Poster Bd #
P1
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Quality Care Symposium
Comparison of molecular testing rates and biomarker positivity by histology among patients (pts) with stage IV non-small cell lung cancer (NSCLC): A quality initiative by Integra Connect PrecisionQ.
First Author: Simon Blanc
Poster
2023 ASCO Annual Meeting
Impact on turnaround times (TAT) among non-squamous non-small cell lung cancer (NSCLC) patients across three time periods with varying biomarker testing techniques.
First Author: Zhen (Jason) Fan
Poster
2023 ASCO Annual Meeting
Real-world testing and treatment patterns among patients with stage IV non-small cell lung cancer: A retrospective observational study.
First Author: Jeffrey A. Scott
Poster
2022 ASCO Quality Care Symposium
Quality initiative (QI) to improve molecular testing in newly diagnosed (ND) stage 4 non-small cell lung cancer (NSCLC-4): An Integra Connect (IC) database study.
First Author: Robert E. Smith